Wave Life Sciences Ltd.
NASDAQ: WVE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Paul Bolno
- Employees
- 317
- Headquarters
- Singapore, Singapore
- IPO year
- 2015
- Market cap
- $1.1B
- Website
- https://wavelifesciences.com
Loading WVE…
Loading profile data…Frequently asked questions about WVE
What does Wave Life Sciences Ltd. (WVE) do?
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific b...
Where does WVE trade?
Wave Life Sciences Ltd. (WVE) trades on the NASDAQ.
What sector is WVE in?
Wave Life Sciences Ltd. (WVE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Wave Life Sciences Ltd.?
Paul Bolno is the chief executive officer of Wave Life Sciences Ltd. (WVE).
Where is Wave Life Sciences Ltd. headquartered?
Wave Life Sciences Ltd. is headquartered in Singapore.
Does WVE pay a dividend?
Wave Life Sciences Ltd. (WVE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WVE go public?
Wave Life Sciences Ltd. (WVE) completed its initial public offering in 2015.